s6y
Company name or ticker
Search
Dyne Therapeutics, Inc.
144
Filing for proposed sale of securities under Rule 144
Filed
Tuesday, April 21, 2026
Accession number
0001628280-26-026328
Documents
primary_doc.xml
144
On sec.gov
Filing index
All files
Complete submission text
SGML header